ANALYST RECOMMENDATIONS : Nvidia, Thermo Fisher Scientific, Danaher, Agilent Technologies, GDS Holdings...

Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.

 

• Advance Auto Parts: UBS cut the target to $230 from $250. Maintains buy rating.
• Agilent Technologies: Credit Suisse reinstated coverage with a recommendation of outperform. PT jumps 23% to $165.
• Apellis Pharmaceuticals: Wedbush maintains neutral rating. Price target up to $55 from $45.
• Aveva: Investec cut the recommendation to hold from buy. PT down 2.9% to 2700 pence.
• Bio-Rad Laboratories: Credit Suisse initiated coverage with a recommendation of outperform. Price target soar 43% to $715.
• ChampionX: Benchmark starts at buy with $32 price target.
• Charles River Laboratories International: Credit Suisse starts with a recommendation of outperform. Price target increases 36% to $285.
• Danaher: Credit Suisse reinstated coverage with a recommendation of outperform. PT up 19% to $340.
• Dick's Sporting Goods: Stifel raised the target to $100 from $84. Maintains hold rating.
• GDS Holdings: Deutsche Bank downgrades to hold from buy. PT jumps 22% to $32.80.
• J. M. Smucker: Barclays maintains equal-weight rating. Price target raised to $160from $140.
• Kimbell Royalty Partners: Citigroup starts at buy with $24 price target.
• Nvidia: Fubon Securities cut the recommendation to neutral from buy. PT up 4.5% to $180.
• O'Reilly Automotive: BofA Securities raises price target to $805 from $730. Maintains buy rating.
• Thermo Fisher Scientific: Credit Suisse has a recommendation of neutral. PT set to $675, implies a 18% increase from last price.
• UDR: Truist Securities adjusts price target to $52 from $50. Maintains hold.
• Urban Outfitters: Barclays raised the target to $19 from $17. Maintains equal-weight rating.